Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Estrogen is important for keeping adult mouse nipple skin healthy by controlling certain cell signals.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

Ishige sinicola, a type of seaweed, may help hair grow by blocking a hair loss-related enzyme and boosting important cell growth.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Indian Gooseberry has potential for cancer prevention and treatment and promotes hair growth.

Cells with active Wnt signaling are less likely to turn into cancer when exposed to a cancer-causing gene.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

Keratin 18 helps diagnose and predict cancer progression and affects cancer growth and spread.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Retinoic acid affects male and female muscle energy use and function differently.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.